Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
Crossref DOI link: https://doi.org/10.1007/s40263-016-0394-8
Published Online: 2016-11-23
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Berger, Thomas
Elovaara, Irina
Fredrikson, Sten
McGuigan, Chris
Moiola, Lucia
Myhr, Kjell-Morten
Oreja-Guevara, Celia
Stoliarov, Igor
Zettl, Uwe K.
Funding for this research was provided by:
Sanofi Genzyme
License valid from 2016-11-23